273 related articles for article (PubMed ID: 35453647)
1. The Role of Hsp27 in Chemotherapy Resistance.
Lampros M; Vlachos N; Voulgaris S; Alexiou GA
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453647
[TBL] [Abstract][Full Text] [Related]
2. Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice.
Kanagasabai R; Karthikeyan K; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H963-H975. PubMed ID: 34477462
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.
Andrieu C; Taieb D; Baylot V; Ettinger S; Soubeyran P; De-Thonel A; Nelson C; Garrido C; So A; Fazli L; Bladou F; Gleave M; Iovanna JL; Rocchi P
Oncogene; 2010 Apr; 29(13):1883-96. PubMed ID: 20101233
[TBL] [Abstract][Full Text] [Related]
4. Untangling the complexity of heat shock protein 27 in cancer and metastasis.
Rizvi SF; Hasan A; Parveen S; Mir SS
Arch Biochem Biophys; 2023 Mar; 736():109537. PubMed ID: 36738981
[TBL] [Abstract][Full Text] [Related]
5. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
6. Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells.
Chen SF; Nieh S; Jao SW; Liu CL; Wu CH; Chang YC; Yang CY; Lin YS
PLoS One; 2012; 7(11):e49275. PubMed ID: 23152886
[TBL] [Abstract][Full Text] [Related]
7. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
8. Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD.
Zoubeidi A; Zardan A; Wiedmann RM; Locke J; Beraldi E; Fazli L; Gleave ME
Cancer Res; 2010 Mar; 70(6):2307-17. PubMed ID: 20197463
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival.
Schultz CR; Golembieski WA; King DA; Brown SL; Brodie C; Rempel SA
Mol Cancer; 2012 Apr; 11():20. PubMed ID: 22480225
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel increases sensitivity of SKOV3 cells to hyperthermia by inhibiting heat shock protein 27.
Kong XX; Jiang S; Liu T; Liu GF; Dong M
Biomed Pharmacother; 2020 Dec; 132():110907. PubMed ID: 33113434
[TBL] [Abstract][Full Text] [Related]
11. Role of HSP27 in the multidrug sensitivity and resistance of colon cancer cells.
Liu Z; Liu Y; Long Y; Liu B; Wang X
Oncol Lett; 2020 Mar; 19(3):2021-2027. PubMed ID: 32194698
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
Zhang Y; Shen X
Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay.
Lee JH; Sun D; Cho KJ; Kim MS; Hong MH; Kim IK; Lee JS; Lee JH
J Cancer Res Clin Oncol; 2007 Jan; 133(1):37-46. PubMed ID: 16906418
[TBL] [Abstract][Full Text] [Related]
15. Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy.
Lelj-Garolla B; Kumano M; Beraldi E; Nappi L; Rocchi P; Ionescu DN; Fazli L; Zoubeidi A; Gleave ME
Mol Cancer Ther; 2015 May; 14(5):1107-16. PubMed ID: 25740245
[TBL] [Abstract][Full Text] [Related]
16. The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer.
Liu CL; Chen SF; Wu MZ; Jao SW; Lin YS; Yang CY; Lee TY; Wen LW; Lan GL; Nieh S
Oncotarget; 2016 Mar; 7(12):14279-90. PubMed ID: 26872057
[TBL] [Abstract][Full Text] [Related]
17. Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells.
Kamada M; So A; Muramaki M; Rocchi P; Beraldi E; Gleave M
Mol Cancer Ther; 2007 Jan; 6(1):299-308. PubMed ID: 17218637
[TBL] [Abstract][Full Text] [Related]
18. Hsp27 modulates p53 signaling and suppresses cellular senescence.
O'Callaghan-Sunol C; Gabai VL; Sherman MY
Cancer Res; 2007 Dec; 67(24):11779-88. PubMed ID: 18089808
[TBL] [Abstract][Full Text] [Related]
19. Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells.
Hansen RK; Parra I; Lemieux P; Oesterreich S; Hilsenbeck SG; Fuqua SA
Breast Cancer Res Treat; 1999 Jul; 56(2):187-96. PubMed ID: 10573111
[TBL] [Abstract][Full Text] [Related]
20. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.
Sims JT; Ganguly SS; Bennett H; Friend JW; Tepe J; Plattner R
PLoS One; 2013; 8(1):e55509. PubMed ID: 23383209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
